Triferic is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Rockwell Medical, Inc. The primary component is Ferric Pyrophosphate Citrate.
Product ID | 57278-314_698459af-84e6-55f5-e053-2a91aa0aac82 |
NDC | 57278-314 |
Product Type | Human Prescription Drug |
Proprietary Name | Triferic |
Generic Name | Ferric Pyrophosphate |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-02-06 |
Marketing Category | NDA / NDA |
Application Number | NDA206317 |
Labeler Name | Rockwell Medical, Inc |
Substance Name | FERRIC PYROPHOSPHATE CITRATE |
Active Ingredient Strength | 5 mg/mL |
Pharm Classes | Iron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-02-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206317 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-02-06 |
Marketing End Date | 2019-11-01 |
Marketing Category | NDA |
Application Number | NDA206317 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-02-06 |
Ingredient | Strength |
---|---|
FERRIC PYROPHOSPHATE CITRATE | 5.44 mg/mL |
SPL SET ID: | 46ec9233-4063-4c48-e054-00144ff8d46c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
57278-314 | Triferic | FERRIC PYROPHOSPHATE |
57278-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE |
57278-316 | Triferic | Ferric Pyrophosphate Citrate |
64811-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TRIFERIC 86036014 4837260 Live/Registered |
ROCKWELL MEDICAL, INC. 2013-08-13 |